Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases

Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases

Bibliographic Details
Main Authors:	Fahimeh Varzideh, Urna Kansakar, Stanislovas S. Jankauskas, Jessica Gambardella, Gaetano Santulli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Endocrinology
Subjects:	cardiometabolism diabetes mellitus endocrine hypertension HFpEF insulin resistance metabolic syndrome
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.772876/full

Similar Items

Aprocitentan: New insights
by: Fahimeh Varzideh, et al.
Published: (2022-12-01)

Molecular Mechanisms Underlying Pluripotency and Self-Renewal of Embryonic Stem Cells
by: Fahimeh Varzideh, et al.
Published: (2023-05-01)

Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
by: Stanislovas S. Jankauskas, et al.
Published: (2024-03-01)

Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress
by: Fahimeh Varzideh, et al.
Published: (2022-02-01)

Functional Role of microRNAs in Regulating Cardiomyocyte Death
by: Urna Kansakar, et al.
Published: (2022-03-01)

Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview
by: Gaetano Santulli, et al.
Published: (2023-09-01)

Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis
by: Fahimeh Varzideh, et al.
Published: (2022-04-01)

miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
by: Urna Kansakar, et al.
Published: (2022-09-01)

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
by: Imma Forzano, et al.
Published: (2022-12-01)

miR-4432 Targets FGFBP1 in Human Endothelial Cells
by: Roberta Avvisato, et al.
Published: (2023-03-01)

Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy
by: Stanislovas S. Jankauskas, et al.
Published: (2024-01-01)

Functional role of miR-34a in diabetes and frailty
by: Pasquale Mone, et al.
Published: (2022-07-01)

Choline supplements: An update
by: Urna Kansakar, et al.
Published: (2023-03-01)

<span style="font-variant: small-caps">l</span>-Arginine and COVID-19: An Update
by: Ayobami Adebayo, et al.
Published: (2021-11-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
by: Kyle B. LaPenna, et al.
Published: (2021-03-01)

COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
by: Stanislovas S. Jankauskas, et al.
Published: (2023-01-01)

Diabetes and restenosis
by: Scott Wilson, et al.
Published: (2022-02-01)

L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults
by: Pasquale Mone, et al.
Published: (2022-04-01)

Tirzepatide: A Systematic Update
by: Imma Forzano, et al.
Published: (2022-11-01)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
by: Zhen Hui Peh, et al.
Published: (2023-06-01)

Inflammation in Metabolic Cardiomyopathy
by: Florian A. Wenzl, et al.
Published: (2021-10-01)

Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications
by: Stanislovas S. Jankauskas, et al.
Published: (2021-07-01)

Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk
by: Scott Wilson, et al.
Published: (2021-04-01)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
by: Bin Dong, et al.
Published: (2022-11-01)

L-Arginine in diabetes: clinical and preclinical evidence
by: Imma Forzano, et al.
Published: (2023-04-01)

Correction: L-Arginine in diabetes: clinical and preclinical evidence
by: Imma Forzano, et al.
Published: (2023-05-01)

Epidemiology of obstructive sleep apnea: What is the contribution of hypertension and arterial stiffness?
by: Pasquale Mone, et al.
Published: (2022-04-01)

The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
by: Becker Al-Khayatt, et al.
Published: (2024-05-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
by: Clement Lau, et al.
Published: (2022-07-01)

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
by: Kramer J. Wahlberg, et al.
Published: (2024-01-01)

Dantrolene improves left ventricular diastolic property in mineralcorticoid-salt-induced hypertensive rats
by: Junya Nawata, et al.
Published: (2023-07-01)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
by: Ahmed Hamam, et al.
Published: (2022-12-01)

Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data
by: Nazli Farajidavar, et al.
Published: (2022-12-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
by: Yohei Sotomi, et al.
Published: (2021-06-01)

Leukocyte count and the risk of adverse outcomes in patients with HFpEF
by: Zhaowei Zhu, et al.
Published: (2021-07-01)

Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
by: Gabrielle Fusco‐Allison, et al.
Published: (2021-10-01)

Heart failure: an update from the last years and a look at the near future
by: Mauro Riccardi, et al.
Published: (2022-12-01)

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
by: Masahiro Seo, et al.
Published: (2023-04-01)

Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension
by: Stanislovas S. Jankauskas, et al.
Published: (2021-02-01)